Photonic cancer detection device developer Mediscience Technology of Cherry Hill, NJ, has entered into a research and development agreement with the Research Foundation of City University of New York (RF-CUNY).
Under terms of the agreement, RF-CUNY will modify and integrate Mediscience's CD-Ratiometer and CD-Map products to couple a microendoscope for molecular fluorescence measurements of breast ducts, the company said.
By AuntMinnie.com staff writers
March 17, 2005
Related Reading
Mediscience adds clinical consultant, January 27, 2005
Copyright © 2005 AuntMinnie.com